• Support center
SkinVision
  • SkinVision Service
  • Skin Cancer Information
    • Skin cancer
    • Melanoma
  • Stories
  • Partners
  • Blog
  • Try SkinVision
SkinVision
  • SkinVision Service
  • Skin Cancer Information
    • Skin cancer
    • Melanoma
  • Stories
  • Partners
  • Blog
  • Try SkinVision

Home » News » Press Release: Skin Cancer App SkinVision Raises $7.6 Million to Further Mission of Saving 250,000 Lives

Press Release: Skin Cancer App SkinVision Raises $7.6 Million to Further Mission of Saving 250,000 Lives

byRickert de Heus inNews posted31 July, 2018
0
1
4 min read

AMSTERDAM, July 30 2018 — The SkinVision team is thrilled to announce the investment of $US7.6 million in the company to support their journey of bringing convenient, accurate and quick recognition of skin cancer. This funding round has been supported by current shareholders LEO Pharma, PHS Capital and a number of new high net worth impact investors.

This investment places SkinVision at the forefront of the integration of machine learning within healthcare. The entire team is incredibly excited as to what this means for the company and its ability to reach tens of millions of individuals with its life saving m-health solution.

Founded in 2012, SkinVision is an awareness and tracking solution that supports individuals with the early recognition of skin cancer. It is the first certified skin cancer application based on extensive clinical trials in partnership with LMU & Erasmus University.

This latest announcement adds to an already incredible year for SkinVision. In May the company won the Dutch Digital Health Challenge for their work with Dutch health insurer CZ. The prize and the hard work committed to further increasing the sensitivity of the service to over 94% has also secured deals with multiple major health insurance providers across Europe and Australasia.

The service uses clinically validated machine learning algorithms to check for visible signs of skin cancer, comparing lesions to the 3.5 million photos already checked by SkinVision dermatologists within its database. The technology indicates which skin spots should be tracked over time, giving a low, medium or high-risk indication within 30 seconds. All high-risk photos receive extra personal advice from doctors on next steps to take within 48 hours.

Speaking of what the funding means for SkinVision, CEO Erik de Heus stated that “This funding will be instrumental in reaching our target of saving 250,000 lives by 2027. We have seen huge growth in the past year and this investment will help us to expand our insurance provider partnerships, ensuring that as many people as possible are provided access to the technology.

We will continue to focus on our target markets UK, Australia and Europe with increased effort to become fully part of the prevention and health care-path for individuals and health stakeholders. Part of this includes localising our services for multiple countries beyond the English, Dutch and German languages now available.

Artificial intelligence has been actively used by SkinVision and offers enormous benefits in terms of health outcomes at reduced cost. This investment allows us to support the transition to value-based care offerings and will show just how large an impact the technology is capable of bringing.”

End

About SkinVision 

SkinVision was founded in 2012 and is an awareness and tracking solution that supports individuals with the early recognition of Melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma and Precancerous Actinic Keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The most recent data shows a sensitivity of 94% and specificity of 80%. Well above that of a GP (sensitivity 60%), a dermatologist (sensitivity 75%) and even a specialist dermatologist (sensitivity 92%).

The company has built up a customer portfolio of 1,200,000 users globally and a database of 3.5 million pictures of suspicious skin conditions. SkinVision is headquartered in Amsterdam, the Netherlands.

More information at www.skinvision.com

Matthew Enevoldson

SkinVision Press

Matthew.Enevoldson@skinvision.com

fundingLEO PharmaPHS Capitalskin cancer
Share this :

More articles

1
Half of Queensland’s female students still attempt to tan
29 January, 2016
Half of Queensland’s female students still attempt to tan

2 min readNew research from the Australian Secondary Students’ Alcohol and Drug survey shows that students in Queensland still attempt to tan in the summer. It seems they are ignoring the fact that tanning has […]

0
Press Release (in Dutch): Nederlandse Innovatie gaat Samen met de NHS Britse Levens Redden
12 March, 2019
Press Release (in Dutch): Nederlandse Innovatie gaat Samen met de NHS Britse Levens Redden

6 min readNederlandse SkinVision gaat 65 miljoen Britten helpen bij de vroegtijdige herkenning van huidkanker Amsterdam – Nederlandse app die helpt bij vroegtijdige herkenning van huidkanker is geselecteerd voor de Britse NHS Innovation Accelerator SkinVision, […]

7
New Zealand Partnership Finds 60 Skin Cancers in First Two Months
20 June, 2018
New Zealand Partnership Finds 60 Skin Cancers in First Two Months

7 min read1 out of every 5 people who have signed up have found a skin cancer early Accuro Insurance, a New Zealand owned and operated health insurance provider, rolled out a new membership benefit […]

0
The Sun: New app scans moles to determine if they’re cancerous – and it’s already saving lives
16 August, 2016
The Sun: New app scans moles to determine if they’re cancerous – and it’s already saving lives

1 min readOne of UK’s biggest newspapers, The Sun, published an article on the UK launch of the SkinVision app. Half of Brits who die of skin cancer could have survived if it had been found […]

4
Generali and SkinVision Offer New Service for Skin Cancer Screening in Germany
24 August, 2018
Generali and SkinVision Offer New Service for Skin Cancer Screening in Germany

2 min readFor about two decades, the number of skin cancers across Europe has been rising steadily.  Every year more than 200,000 people in Germany are diagnosed with the disease – and the trend is […]

0
SkinVision to Join NHS Innovation Accelerator
5 March, 2019
SkinVision to Join NHS Innovation Accelerator

6 min readApp empowering people to monitor themselves for early signs of skin cancer selected to join NHS Innovation Accelerator SkinVision, An app which empowers people to monitor themselves for early signs of skin cancer […]

It saved my life, it could save many more -- Nikie Duddrige

Keep your skin healthy and find skin cancer early.

Peace of mind with an accurate risk indication.

Peace of mind with an accurate risk indication.

Immediate response from SkinVision dermatologists.

Immediate response from SkinVision dermatologists.

Find skin cancer early. It can save your life.

Find skin cancer early. It can save your life.

Download SkinVision now for free

Information

  • Skin cancer
    • Skin cancer pictures
  • Melanoma
    • Melanoma pictures
  • Normal moles pictures

Company

  • About us
  • Research
  • Careers
  • Terms and conditions
  • Privacy

Business

  • Press
  • Partners
  • For companies

Support

  • FAQ
  • Contact
  • Instructions For Use
Copyright © 2019 SkinVision - Skin cancer melanoma detection app. All Rights Reserved.